Universitat de València;Institut Químic de Sarrià CETS Fundació Privada;Institut Univ. de Ciència i Tecnologia, S.A.
发明人:
申请号：
EP15797633.3
公开号：
EP3217984B1
申请日:
2015.11.13
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present invention relates to caffeine for use in the treatment of myotonic dystrophy type 1 and type 2. The present invention also relates to compositions comprising caffeine for use in the treatment of myotonic dystrophy type 1 and type 2.
